Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib

被引:37
作者
Hayashi, Nobuyoshi [1 ,2 ]
Fujita, Akihisa [1 ]
Saikai, Toyohiro [1 ]
Takabatake, Hirotugu [1 ]
Sotoshiro, Mie [1 ]
Sekine, Kyuutarou [1 ]
Kawana, Akihiko [2 ]
机构
[1] Sapporo Minamisanjyou Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan
[2] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Pulm Med, Tokorozawa, Saitama, Japan
关键词
LCNEC; pulmonary neuroendocrine carcinoma; ALK rearrangement and alectinib; POSITIVE LUNG-CANCER; EML4-ALK FUSION; CRIZOTINIB; ADENOCARCINOMA; CHEMOTHERAPY; INHIBITOR; COMPONENT;
D O I
10.2169/internalmedicine.9368-17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anaplastic lymphoma kinase (ALK) rearrangement is most commonly observed in lung adenocarcinoma in a subset of lung cancer. Large cell neuroendocrine carcinoma (LCNEC) harboring an ALK rearrangement is very rare. Based on the findings from a transbronchial lung biopsy, a 75-year-old non-smoking woman was diagnosed with LCNEC with multiple liver and bone metastases. After seven cycles of cytotoxic chemotherapy, her genotype testing demonstrated ALK rearrangement. Subsequently, she was administered alectinib and exhibited a partial response.
引用
收藏
页码:713 / 716
页数:4
相关论文
共 13 条
[1]   Pulmonary Large-Cell Neuroendocrine Carcinoma From Epidemiology to Therapy [J].
Fasano, Morena ;
Della Corte, Carminia Maria ;
Papaccio, Federica ;
Ciardiello, Fortunato ;
Morgillo, Floriana .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (08) :1133-1141
[2]   A Case of Atypical Carcinoid Harboring Variant 3a/b EML4-ALK Rearrangement [J].
Fukuizumi, Aya ;
Akagi, Kiwamu ;
Sakai, Hiroshi .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (10) :E104-E106
[3]   Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial [J].
Hida, Toyoaki ;
Nokihara, Hiroshi ;
Kondo, Masashi ;
Kim, Young Hak ;
Azuma, Koichi ;
Seto, Takashi ;
Takiguchi, Yuichi ;
Nishio, Makoto ;
Yoshioka, Hiroshige ;
Imamura, Fumio ;
Hotta, Katsuyuki ;
Watanabe, Satoshi ;
Goto, Koichi ;
Satouchi, Miyako ;
Kozuki, Toshiyuki ;
Shukuya, Takehito ;
Nakagawa, Kazuhiko ;
Mitsudomi, Tetsuya ;
Yamamoto, Nobuyuki ;
Asakawa, Takashi ;
Asabe, Ryoichi ;
Tanaka, Tomohiro ;
Tamura, Tomohide .
LANCET, 2017, 390 (10089) :29-39
[4]  
Kato M., 2015, MED J AIZAWA HOSP, V13, P57
[5]   Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor [J].
Nakajima, Masayuki ;
Uchiyama, Naoki ;
Shigemasa, Rie ;
Matsumura, Takeshi ;
Matsuoka, Ryota ;
Nomura, Akihiro .
INTERNAL MEDICINE, 2016, 55 (21) :3151-3153
[6]   A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4-ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib [J].
Omachi, Naoki ;
Shimizu, Shigeki ;
Kawaguchi, Tomoya ;
Tezuka, Kenji ;
Kanazu, Masaki ;
Tamiya, Akihiro ;
Asami, Kazuhiro ;
Okishio, Kyoichi ;
Kitaichi, Masanori ;
Atagi, Shinji .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) :E40-E42
[7]   Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study [J].
Ou, Sai-Hong Ignatius ;
Ahn, Jin Seok ;
De Petris, Luigi ;
Govindan, Ramaswamy ;
Yang, James Chih-Hsin ;
Hughes, Brett ;
Lena, Herve ;
Moro-Sibilot, Denis ;
Bearz, Alessandra ;
Ramirez, Santiago Viteri ;
Mekhail, Tarek ;
Spira, Alexander ;
Bordogna, Walter ;
Balas, Bogdana ;
Morcos, Peter N. ;
Monnet, Annabelle ;
Zeaiter, Ali ;
Kim, Dong-Wan .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) :661-+
[8]   Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer [J].
Shaw, Alice T. ;
Kim, Dong-Wan ;
Nakagawa, Kazuhiko ;
Seto, Takashi ;
Crino, Lucio ;
Ahn, Myung-Ju ;
De Pas, Tommaso ;
Besse, Benjamin ;
Solomon, Benjamin J. ;
Blackhall, Fiona ;
Wu, Yi-Long ;
Thomas, Michael ;
O'Byrne, Kenneth J. ;
Moro-Sibilot, Denis ;
Camidge, D. Ross ;
Mok, Tony ;
Hirsh, Vera ;
Riely, Gregory J. ;
Iyer, Shrividya ;
Tassell, Vanessa ;
Polli, Anna ;
Wilner, Keith D. ;
Jaenne, Pasi A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (25) :2385-2394
[9]  
Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]
[10]   An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene [J].
Toyokawa, Gouji ;
Takenoyama, Mitsuhiro ;
Taguchi, Kenichi ;
Toyozawa, Ryo ;
Inamasu, Eiko ;
Kojo, Miyako ;
Shiraishi, Yoshimasa ;
Morodomi, Yosuke ;
Takenaka, Tomoyoshi ;
Hirai, Fumihiko ;
Yamaguchi, Masafumi ;
Seto, Takashi ;
Shimokawa, Mototsugu ;
Ichinose, Yukito .
LUNG CANCER, 2013, 81 (03) :487-490